首页> 外文期刊>Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society >Keloid-derived, plasma/fibrin-based skin equivalents generate de novo dermal and epidermal pathology of keloid fibrosis in a mouse model
【24h】

Keloid-derived, plasma/fibrin-based skin equivalents generate de novo dermal and epidermal pathology of keloid fibrosis in a mouse model

机译:来自瘢痕loid的血浆/纤维蛋白基皮肤等效物在小鼠模型中产生瘢痕loid纤维化的从头开始的真皮和表皮病理学

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Keloids are wounding-induced tumor-like human scars. Unclear etiology and lack of animal models to reveal disease mechanisms and invent therapies deepen the grievous health and psychosocial state of vulnerable individuals. Epitomizing the injury-repair environment which triggers and fosters keloid formation and essential dermal/epidermal interactions in disease development, the novel animal model was established by implanting porous polyethylene ring-supported plasma/fibrin-based epidermal-dermal skin constructs on the dorsum of athymic NU/J mice. The implants were stable to 18 weeks, contained abundant human cells, and remodeled to yield scar architecture characteristic of keloid fibrosis compared with normal implants and clinical specimens: (1) macroscopic convex or nodular scar morphology; (2) morphogenesis and accumulation of large collagen bundles from collagen-null initial constructs; (3) epidermal hyperplasia, aberrant epidermal-dermal patency, and features of EMT; (4) increased vasculature, macrophage influx, and aggregation; and (5) temporal-spatial increased collagen-inducing PAI-1 and its interactive partner uPAR expression. Development of such pathology in the NU/J host suggests that T-cell participation is less important at this stage than at keloid initiation. These accessible implants also healed secondary excisional wounds, enabling clinically relevant contemporaneous wounding and treatment strategies, and evaluation. The model provides a robust platform for studying keloid formation and testing knowledge-based therapies.
机译:瘢痕loid是伤口诱导的肿瘤样人类疤痕。病因不明,缺乏动物模型来揭示疾病机制和发明疗法,加深了脆弱个体的严重健康和社会心理状况。在疾病发展过程中引发并促进瘢痕loid形成和必要的皮肤/表皮相互作用的损伤修复环境的缩影,通过在无胸腺的背部植入多孔聚乙烯环支撑的血浆/纤维蛋白基表皮-皮肤结构,建立了新型动物模型。 NU / J小鼠。与正常的植入物和临床标本相比,植入物稳定至18周,包含丰富的人类细胞,并进行了改造,以产生瘢痕loid纤维化的瘢痕结构特征:(1)宏观的凸形或结节性瘢痕形态; (2)胶原蛋白无效的初始构建体的大胶原束的形态发生和积累; (3)表皮增生,表皮-皮肤异常通畅和EMT特征; (4)脉管系统,巨噬细胞流入和聚集增加; (5)时空诱导胶原诱导的PAI-1及其相互作用伴侣uPAR表达的增加。在NU / J宿主中这种病理学的发展表明,在这一阶段,T细胞参与的重要性不如瘢痕loid起始。这些可及的植入物还治愈了继发性切除伤口,从而实现了与临床相关的同期伤口和治疗策略以及评估。该模型为研究瘢痕loid形成和测试基于知识的疗法提供了一个强大的平台。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号